Clinical trial

Comparison of Postoperative Analgesic Effects of Ultrasonography-Guided Paravertebral Block and Subcostal Transversus Abdominis Plane Block in Patients Undergoing Laparoscopic Nephrectomy

Name
2022-1276671
Description
Most of the patients undergoing laparoscopic partial/radical nephrectomy can experience moderate or severe postoperative pain, and inadequate control of this pain can cause negative consequences such as development of chronic pain, pulmonary and cardiac events, and side effects of long term opioid usage. Due to these adverse outcomes, ultrasonography-guided plane blocks can be beneficial for these patients to decrease opioid consumption. In this study, the investigators aim to compare ultrasonography-guided plane blocks: Paravertebral block and subcostal transversus abdominis plane block and traditional method: patient controlled analgesia with opioids. The investigators hypothesized that analgesic efficacy in both paravertebral and subcostal TAP blocks will have similar outcomes but better than traditional method.
Trial arms
Trial start
2023-02-15
Estimated PCD
2023-10-01
Trial end
2024-02-01
Status
Completed
Treatment
Bupivacain
%0,25
Arms:
Paravertebral Block Group, Subcostal Transversus Abdominis Plane Block Group
Other names:
Marcaine
Morphine
In this group, patients will be postoperatively administered patient-controlled analgesia with morphine only.
Arms:
Intravenous Patient Controlled Analgesia, Paravertebral Block Group, Subcostal Transversus Abdominis Plane Block Group
Other names:
Morphine Sulfate
Size
91
Primary endpoint
Postoperative Intravenous Total Morphine Consumption
Up to 24 hours
Eligibility criteria
Inclusion Criteria: * Age of 18-75 * Patients who are ASA (American Society of Anesthesiology): I-II * Patients who will have laparoscopic partial/radical nephrectomy * Patients who volunteer to participate in the study Exclusion Criteria: * Patients with any kind of coagulopathy * Patients with severe cardiac, pulmonary, renal or liver disease * Patients who have difficulty comprehending the IV PCA device * Patients with local anesthetic allergy * Patients with chronic opioid use
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'RANDOMISED SINGLE BLINDED INTERVENTIONAL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 91, 'type': 'ACTUAL'}}
Updated at
2024-03-12

1 organization

2 products

4 indications

Product
Bupivacain
Indication
Analgesic
Indication
Anesthesia
Indication
Pain
Indication
Postoperative
Product
Morphine